This April's Clovertex Target of the Month is the Androgen Receptor (AR), a critical protein involve...

Commentary on everything related to cryo-EM in drug discovery.
This April's Clovertex Target of the Month is the Androgen Receptor (AR), a critical protein involve...
Here are your MiTeGen Hottest Tweets in SBDD, featuring heated discussions about the Inflation Reduc...
This March's Clovertex Target of the Month is CXCR4 following a Regeneron preprint that presents tet...
Here are your MiTeGen Hottest Tweets in SBDD including a new cryo-EM study revealing the missing pie...
In a recent collaboration, Proteros and Merck KGaA published a study in the Journal of Molecular Bio...
This February, we're excited to shine our Clovertex Target of the Month spotlight on the estrogen re...
Shots fired: When is it time-resolved? What's the resolution? China to break into TEM? JEOL = Concor...
This January 2024, we're spotlighting Bruton's tyrosine kinase (BTK) as our Clovertex Target of the ...
Medicine experienced a monumental moment in 2023 with the recognition of BCL11A as the 2023 Cloverte...
Amidst a flurry of big pharma deals, the Muscarinic acetylcholine receptor subtype M4 has emerged as...